Din culisele bătăliei: Proprietatea Intelectuală versus COVID-19
From the backstage of the battle: Intellectual property versus COVID-19

Summary/Abstract: The severity of the coronavirus pandemic and the concomitant demand for treatments and vaccines have heightened the imperative for the global patent system to respond rapidly to the needs of the life sciences & pharma industry. However, some voices have expressed concern that intellectual property (IP) protection for COVID-19 vaccines and therapies would inhibit their development, availability or accessibility. On the other hand, proponents of intellectual property protection counter that it is vital for the development of such products. The reality is, however, that opposition to IP protection for vaccines, therapies, diagnostics and other technologies aimed at combating and treating COVID-19 can only limit the prevention, treatment and eradication of the disease. I propose below to tentatively outline some pros, cons and considerations regarding IP protection for COVID-19 treatments, vaccines, diagnostics and other technologies.

• Details
• Contents